已发表论文

谷醇溶谷蛋白玉米蛋白作为用于癌症治疗的多功能药物递送系统的研究进展和前景

 

Authors Luo X , Wu S, Xiao M, Gu H, Zhang H, Chen J , Liu Y , Zhang C, Zhang J 

Received 28 December 2022

Accepted for publication 6 May 2023

Published 15 May 2023 Volume 2023:18 Pages 2589—2621

DOI https://doi.org/10.2147/IJN.S402891

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. Anderson Oliveira Lobo


Abstract: Zein is a type of prolamine protein that is derived from corn, and it has been recognized by the US FDA as one of the safest biological materials available. Zein possesses valuable characteristics that have made it a popular choice for the preparation of drug carriers, which can be administered through various routes to improve the therapeutic effect of antitumor drugs. Additionally, zein contains free hydroxyl and amino groups that offer numerous modification sites, enabling it to be hybridized with other materials to create functionalized drug delivery systems. However, despite its potential, the clinical translation of drug-loaded zein-based carriers remains challenging due to insufficient basic research and relatively strong hydrophobicity. In this paper, we aim to systematically introduce the main interactions between loaded drugs and zein, administration routes, and the functionalization of zein-based antitumor drug delivery systems, in order to demonstrate its development potential and promote their further application. We also provide perspectives and future directions for this promising area of research.
Keywords: zein, nanomedicine, drug delivery, antitumor